Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $7.9100 (1.28%) ($7.9100 - $7.9100) on Wed. Feb. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.36% (three month average) | RSI | 71 | Latest Price | $7.9100(1.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 3.7% a day on average for past five trading days. | Weekly Trend | CAPR advances 10.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) VCIT(78%) JNK(67%) SPY(65%) EMHY(64%) IVE(59%) | Factors Impacting CAPR price | CAPR will decline at least -3.68% in a week (0% probabilities). VXX(-28%) UUP(-26%) USO(-7%) TBT(-24%) PEJ(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.68% (StdDev 7.36%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.48(5.75%) | 10 Day Moving Average | $7.02(12.68%) | 20 Day Moving Average | $6.33(24.96%) | To recent high | -0.4% | To recent low | 50.7% | Market Cap | $156m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |